Carbamate and N-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors
出版年份 2021 全文链接
标题
Carbamate and N-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors
作者
关键词
-
出版物
ACS Medicinal Chemistry Letters
Volume 12, Issue 3, Pages 389-396
出版商
American Chemical Society (ACS)
发表日期
2021-02-26
DOI
10.1021/acsmedchemlett.0c00525
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Positional Analogue Scanning: An Effective Strategy for Multiparameter Optimization in Drug Design
- (2020) Lewis D. Pennington et al. JOURNAL OF MEDICINAL CHEMISTRY
- Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1)
- (2020) Catherine White et al. ACS Medicinal Chemistry Letters
- Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors
- (2020) Qinglin Pu et al. ACS Medicinal Chemistry Letters
- Applications of amide isosteres in medicinal chemistry
- (2019) Shaoyi Sun et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of Clinical Candidate (1R,4r)-4-((R)-2-((S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1
- (2019) Sanjeev Kumar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Imidazoisoindole Derivatives as Highly Potent and Orally Active Indoleamine-2,3-dioxygenase Inhibitors
- (2019) Wangyang Tu et al. ACS Medicinal Chemistry Letters
- Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1)
- (2019) Ute F. Röhrig et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy
- (2019) Hongjun Zhang et al. ACS Medicinal Chemistry Letters
- Small Molecules Drive Big Improvements in Immuno-Oncology Therapies
- (2018) Bayard R. Huck et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form
- (2018) Micah T. Nelp et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epacadostat (E) plus pembrolizumab (P) versus pembrolizumab alone in patients (pts) with unresectable or metastatic melanoma: Results of the phase 3 ECHO-301/KEYNOTE-252 study.
- (2018) Georgina V. Long et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting indoleamine-2,3-dioxygenase in cancer: Scientific rationale and clinical evidence
- (2018) Biagio Ricciuti et al. PHARMACOLOGY & THERAPEUTICS
- The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization
- (2017) Lewis D. Pennington et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate
- (2017) Stefano Crosignani et al. JOURNAL OF MEDICINAL CHEMISTRY
- INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology
- (2017) Eddy W. Yue et al. ACS Medicinal Chemistry Letters
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space
- (2016) Nicholas A. Meanwell CHEMICAL RESEARCH IN TOXICOLOGY
- Design of New Ligands for the Palladium-Catalyzed Arylation of α-Branched Secondary Amines
- (2015) Nathaniel H. Park et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cancer immunotherapy: harnessing the immune system to battle cancer
- (2015) Yiping Yang JOURNAL OF CLINICAL INVESTIGATION
- Applications of Fluorine in Medicinal Chemistry
- (2015) Eric P. Gillis et al. JOURNAL OF MEDICINAL CHEMISTRY
- Organic Carbamates in Drug Design and Medicinal Chemistry
- (2015) Arun K. Ghosh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Big opportunities for small molecules in immuno-oncology
- (2015) Jerry L. Adams et al. NATURE REVIEWS DRUG DISCOVERY
- Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
- (2014) George C. Prendergast et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Host Indoleamine 2,3-Dioxygenase: Contribution to Systemic Acquired Tumor Tolerance
- (2012) Theodore S. Johnson et al. IMMUNOLOGICAL INVESTIGATIONS
- Metabolism-guided drug design
- (2012) Antonia F. Stepan et al. MedChemComm
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
- (2011) Christiane A. Opitz et al. NATURE
- Optimization of Pharmacokinetics through Manipulation of Physicochemical Properties in a Series of HCV Inhibitors
- (2011) Scott E. Lazerwith et al. ACS Medicinal Chemistry Letters
- The Many Roles for Fluorine in Medicinal Chemistry
- (2008) William K. Hagmann JOURNAL OF MEDICINAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started